Sumitomo Heavy Industries (6302) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
31 Oct, 2025Executive summary
Orders rose year-over-year by ¥123.9 billion (19%) to ¥789.7 billion, with broad-based demand recovery except for semiconductor-related products.
Net sales declined by 2.4% (¥18.9 billion) to ¥753.2 billion, mainly due to lower sales in Industrial Machinery and Logistics & Construction and a smaller backlog.
Operating profit dropped 15% year-over-year to ¥34.7 billion, reflecting weaker segment performance.
Ordinary profit fell by 11% to ¥31.5 billion; profit attributable to owners of parent decreased 18% to ¥19.9 billion.
Segment reconfiguration was implemented to streamline management and promote synergies, affecting year-on-year comparisons.
Financial highlights
Operating profit margin decreased by 0.7pt to 4.6% year-over-year.
Ordinary profit margin was 4.2% (down 0.4pt year-over-year).
Comprehensive income dropped 73% year-over-year to ¥7.97 billion.
Equity ratio at 50.2%, down 0.6pt from previous year-end.
Operating cash flow for the period was ¥44.6 billion, up ¥34.0 billion year-over-year.
Outlook and guidance
FY2025 full-year net sales forecast at ¥1,050.0 billion and operating profit at ¥50.0 billion; ordinary profit forecast at ¥44.0 billion and profit attributable to owners of parent at ¥25.0 billion.
Annual dividend forecast is ¥125 per share.
Latest events from Sumitomo Heavy Industries
- Orders up 24% YoY, profit attributable to owners of parent up 301%, FY2026 profit to rise.6302
Q4 202510 Feb 2026 - Sales and profit rose, but orders and full-year outlook declined amid global uncertainty.6302
Q2 20242 Feb 2026 - Orders up 18% but profits fell; FY2025 guidance cut amid weak China and semiconductor demand.6302
Q2 202523 Nov 2025 - Profits fell sharply on weak demand, but net sales stayed flat on backlogs and FX gains.6302
Q3 202413 Jun 2025 - Orders surged but profits fell; full-year outlook remains positive.6302
Q1 20256 Jun 2025 - Net profit plunged 76% on impairment, but FY2025 targets a strong earnings recovery.6302
Q4 20245 Jun 2025